Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07009340 · ClinicalTrials.gov registry record
Retrospective Observational Study of Patients Who Have Undergone Coronary Artery Bypass Graft (CABG) and/or Cardiac Valve Surgery
A clinical trial of Post-discharge Outcomes, sponsored by Renibus Therapeutics.
- Active
- Registry status
- 200
- Enrollment target
- 4
- Study locations
NCT07009340 is a study of Post-discharge Outcomes that is active but no longer recruiting, run by Renibus Therapeutics. The registered enrollment target is 200 participants. The trial reports 4 study locations across 4 states.
The verdict
NCT07009340, a study of Post-discharge Outcomes, is active but no longer recruiting, sponsored by Renibus Therapeutics.
- ACTIVE NOT RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study is a retrospective chart abstraction for subjects who were enrolled in REN-004. As a retrospective study, all data will be abstracted from the medical records.
Conditions Studied
Study Locations (4)
Alabama
- Heart Center Research, LLC - Huntsville
Indiana
- Lutheran Medical Center - Fort Wayne
Michigan
- My Michigan Medical Center - Midland
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-11-18 |
| Est. Completion | 2025-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07009340
The ClinicalTrials.gov registry entry for NCT07009340 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Renibus Therapeutics, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post-discharge Outcomes appearing as the primary indexed condition, and to 0 interventions.
NCT07009340 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Alabama, Indiana, Michigan.
Frequently Asked Questions
What is clinical trial NCT07009340 about?
NCT07009340 is a clinical study titled "Retrospective Observational Study of Patients Who Have Undergone Coronary Artery Bypass Graft (CABG) and/or Cardiac Valve Surgery". This study is a retrospective chart abstraction for subjects who were enrolled in REN-004. As a retrospective study, all data will be abstracted from the medical records.
What is the current status of trial NCT07009340?
This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2023-11-18. Estimated completion is 2025-06-30.
What conditions does trial NCT07009340 study?
This clinical trial studies the following conditions: Post-discharge Outcomes.
Who is sponsoring clinical trial NCT07009340?
This trial is sponsored by Renibus Therapeutics, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07009340 being conducted?
This trial has 4 study locations across Alabama, Indiana, Michigan, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.